NasdaqGM - Nasdaq Real Time Price USD
KalVista Pharmaceuticals, Inc. (KALV)
11.34
-0.30
(-2.58%)
At close: May 14 at 4:00:01 PM EDT
10.82
-0.52
(-4.59%)
After hours: May 14 at 6:17:29 PM EDT
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
---|---|---|---|
AUDHYA PAUL K Officer | Sale | Feb 24, 2025 | 102,940 |
CHA ALBERT Director | Conversion of Exercise of derivative security | Sep 11, 2023 | 0 |
CROCKETT THOMAS ANDREW Chief Executive Officer | Sale | Feb 20, 2024 | 211,203 |
FEENER EDWARD P Officer | Sale | May 20, 2024 | 72,858 |
PALLEIKO BENJAMIN L Chief Executive Officer | Sale | Mar 7, 2025 | 287,811 |
VENROCK HEALTHCARE CAPITAL PARTNERS II, LP Beneficial Owner of more than 10% of a Class of Security | Purchase | Jan 4, 2024 | -- |
VENROCK HEALTHCARE CAPITAL PARTNERS III, L.P. Beneficial Owner of more than 10% of a Class of Security | Purchase | Feb 13, 2025 | -- |
VHCP MANAGEMENT L L C Beneficial Owner of more than 10% of a Class of Security | Purchase | Dec 29, 2023 | -- |
YEA CHRISTOPHER M Officer | Sale | Feb 24, 2025 | 93,952 |
Related Tickers
PHVS Pharvaris N.V.
16.07
-0.25%
URGN UroGen Pharma Ltd.
9.87
-2.66%
TARS Tarsus Pharmaceuticals, Inc.
42.90
+3.47%
ATXS Astria Therapeutics, Inc.
3.9700
+1.79%
ABEO Abeona Therapeutics Inc.
5.39
-4.26%
IDYA IDEAYA Biosciences, Inc.
17.10
-2.01%
TRML Tourmaline Bio, Inc.
15.50
-0.26%
EWTX Edgewise Therapeutics, Inc.
14.55
-2.28%
CRNX Crinetics Pharmaceuticals, Inc.
31.29
+1.10%
KURA Kura Oncology, Inc.
5.73
-1.21%